Press Release

PhRMA Statement on Patent Reform

PhRMA March 9, 2011

Washington, D.C. (March 9, 2011) — The Pharmaceutical Research and Manufacturers of America President and CEO John Castellani today released the following statement regarding the Senate passage of the patent reform bill:

“We congratulate Senator Leahy and other Congressional leaders who supported the America Invents Act, including the members of the Senate Judiciary Committee, who previously came together for a bipartisan and unanimous committee vote. Today's Senate passage sends a clear message: that these leaders are willing to take steps toward creating an environment in America that will support innovation and, with it, the jobs that it provides. Senator Leahy's bill is the result of his strong commitment to significant dialogue and collaboration to create a robust and fair system, applicable across a broad range of business sectors, that will protect the ability of patent holders to develop their ideas into usable products - which, in the biopharmaceutical sector, can be life-saving.

“Senator Leahy’s commitment to this bill – and the support of its cosponsors and those who voted in its favor – demonstrates their appreciation for the importance of intellectual property protection to the U.S. economy and to the jobs – and life-saving innovation – that it provides.

“As the bill moves forward, we hope that Members of the House of Representatives will share in that commitment and approve a bill that mirrors the Senate’s commitment to innovation.”

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $45.8 billion in 2009 in discovering and developing new medicines. Industry-wide research and investment reached a record $65.3 billion in 2009.

PhRMA Internet Address:
For information on how innovative medicines save lives, visit:
For information on the Partnership for Prescription Assistance, visit:

For information on the danger of imported drugs, visit:

For more information on public health emergencies, visit